Results 31 to 40 of about 166,404,517 (251)

ANAEMIA IN ELDERLY: A BENIGN CONDITION OR AN EARLY WARNING? - A HOSPITAL BASED STUDY

Pakistan Armed Forces Medical Journal, 2016
Objective: To determine the frequency of etiological subtypes of anaemia in geriatric patients in hospital practice. Study Design: Descriptive study.
Shamaila Burney, Saqib Qayyum Ahmad, Rehan Masroor   +2 more
doaj   +2 more sources

Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study

BMC Nephrology
Background Iron deficiency is a major contributor to anaemia in chronic kidney diseases. The association of anaemia and iron deficiency with health-related quality of life in Japanese patients with non-dialysis chronic kidney disease has not been ...
Reiko Okubo, Tomohiro Ohigashi, Masahide Kondo, Ryoya Tsunoda, Hirayasu Kai, Chie Saito, Junichi Hoshino, Hirokazu Okada, Ichiei Narita, Shoichi Maruyama, Takashi Wada, Kunihiro Yamagata   +11 more
doaj   +1 more source

Treatment of Anemia in Patients with Inflammatory Bowel Diseases

Gastroenterologìa, 2014
Anaemia is a frequent systemic manifestation of inflammatory bowel diseases (IBD) which has significant impact on the quality of life, is associated with severity of disease and resistance to therapy.
T.I. Boyko, O.V. Sorochan, M.V. Stoykevich, N.M. Mosalova, T.N. Tolstikova   +4 more
doaj   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Prevalence of Anaemia and Evaluation of Transferrin Receptor (sTfR) in the Diagnosis of Iron Deficiency in the Hospitalized Elderly Patients: Anaemia Clinical Studies in Chile

Anemia, 2012
Iron constitutes the most prevalent nutritional deficiency worldwide. In Chile, anaemia epidemiological data is scarce, evaluating mainly children and women.
Mauricio López-Sierra, Susana Calderón, Jorge Gómez, Lilian Pilleux   +3 more
doaj   +1 more source

Association Between Individualized Education for Kidney Replacement Therapy Modality Selection and Peritoneal Dialysis Initiation: A Cross‐Sectional Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito, Ryuichi Yoshimura, Takaki Yamauchi, Yuta Funakoshi, Hirotaka Sonoda, Seiji Kobayashi, Hiroyuki Terawaki, Takafumi Ito   +7 more
wiley   +1 more source

Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. [PDF]

, 2011
: Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and death in patients with moderate or severe obstruction.
van der Molen, T, Jones PW, Jones, P., van der Molen, T., Price, D, Price, David, Jones, PW, van der Molen, Thys, Jones, Paul W., Price D, van der Molen T, Price, D.   +11 more
core   +2 more sources

The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease

Case Reports in Oncology, 2021
Haematopoietic insufficiency is the treatment target of lower-risk myelodysplastic syndrome (MDS). Although erythropoiesis-stimulating agents (ESAs) are generally effective for treating anaemia, resistance can develop.
Ryujiro Hara, Naoki Goto, Daisuke Furuya, Toshihiko Kitahara, Hiroki Numata, Shigeki Watanabe, Hiroshi Kawada, Kiyoshi Ando   +7 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source